Search Page

1

Cite

Share

Young adult psychological outcome after puberty suppression and gender reassignment.

de Vries AL, McGuire JK, Steensma TD, Wagenaar EC, Doreleijers TA, Cohen-Kettenis PT. de Vries AL, et al. Among authors: wagenaar ec. Pediatrics. 2014 Oct;134(4):696-704. doi: 10.1542/peds.2013-2958. Epub 2014 Sep 8. Pediatrics. 2014. PMID: 25201798

Cite

Share

2

Cite

Share

[Acute kidney injury, an avoidable problem].

van Vugt LK, Wagenaar E, van Etten RW. van Vugt LK, et al. Among authors: wagenaar e. Ned Tijdschr Geneeskd. 2021 Apr 8;165:D5528. Ned Tijdschr Geneeskd. 2021. PMID: 33914430 Dutch.

Cite

Share

3

Cite

Share

Multidrug resistance and the role of P-glycoprotein knockout mice.

Schinkel AH, Mol CA, Wagenaar E, van Deemter L, Smit JJ, Borst P. Schinkel AH, et al. Among authors: wagenaar e. Eur J Cancer. 1995 Jul-Aug;31A(7-8):1295-8. doi: 10.1016/0959-8049(95)00130-b. Eur J Cancer. 1995. PMID: 7577039 Review.

Cite

Share

4

Cite

Share

Classical and novel forms of multidrug resistance and the physiological functions of P-glycoproteins in mammals.

Borst P, Schinkel AH, Smit JJ, Wagenaar E, Van Deemter L, Smith AJ, Eijdems EW, Baas F, Zaman GJ. Borst P, et al. Among authors: wagenaar e. Pharmacol Ther. 1993 Nov;60(2):289-99. doi: 10.1016/0163-7258(93)90011-2. Pharmacol Ther. 1993. PMID: 7912835 Review.

Cite

Share

5

Cite

Share

ABC transporters Mdr1a/1b, Bcrp1, Mrp2 and Mrp3 determine the sensitivity to PhIP/DSS-induced colon carcinogenesis and inflammation.

Durmus S, van der Valk M, Teunissen SF, Song JY, Wagenaar E, Beijnen JH, Schinkel AH. Durmus S, et al. Among authors: wagenaar e. Arch Toxicol. 2019 Mar;93(3):775-790. doi: 10.1007/s00204-019-02394-w. Epub 2019 Jan 30. Arch Toxicol. 2019. PMID: 30701287

Cite

Share

6

Cite

Share

Hepatocellular Shuttling and Recirculation of Sorafenib-Glucuronide Is Dependent on Abcc2, Abcc3, and Oatp1a/1b.

Vasilyeva A, Durmus S, Li L, Wagenaar E, Hu S, Gibson AA, Panetta JC, Mani S, Sparreboom A, Baker SD, Schinkel AH. Vasilyeva A, et al. Among authors: wagenaar e. Cancer Res. 2015 Jul 1;75(13):2729-36. doi: 10.1158/0008-5472.CAN-15-0280. Epub 2015 May 7. Cancer Res. 2015. PMID: 25952649 Free PMC article.

Cite

Share

7

Cite

Share

Brain accumulation of osimertinib and its active metabolite AZ5104 is restricted by ABCB1 (P-glycoprotein) and ABCG2 (breast cancer resistance protein).

van Hoppe S, Jamalpoor A, Rood JJM, Wagenaar E, Sparidans RW, Beijnen JH, Schinkel AH. van Hoppe S, et al. Among authors: wagenaar e. Pharmacol Res. 2019 Aug;146:104297. doi: 10.1016/j.phrs.2019.104297. Epub 2019 Jun 5. Pharmacol Res. 2019. PMID: 31175939

Cite

Share

8

Cite

Share

P-glycoprotein (MDR1/ABCB1) restricts brain accumulation and cytochrome P450-3A (CYP3A) limits oral availability of the novel ALK/ROS1 inhibitor lorlatinib.

Li W, Sparidans RW, Wang Y, Lebre MC, Wagenaar E, Beijnen JH, Schinkel AH. Li W, et al. Among authors: wagenaar e. Int J Cancer. 2018 Oct 15;143(8):2029-2038. doi: 10.1002/ijc.31582. Epub 2018 Jul 10. Int J Cancer. 2018. PMID: 29744867 Free article.

Cite

Share

9

Cite

Share

P-glycoprotein (MDR1/ABCB1) and Breast Cancer Resistance Protein (BCRP/ABCG2) affect brain accumulation and intestinal disposition of encorafenib in mice.

Wang J, Gan C, Sparidans RW, Wagenaar E, van Hoppe S, Beijnen JH, Schinkel AH. Wang J, et al. Among authors: wagenaar e. Pharmacol Res. 2018 Mar;129:414-423. doi: 10.1016/j.phrs.2017.11.006. Epub 2017 Nov 14. Pharmacol Res. 2018. PMID: 29155017

Cite

Share

10

Cite

Share

WD repeat-containing protein 5 (WDR5) localizes to the midbody and regulates abscission.

Bailey JK, Fields AT, Cheng K, Lee A, Wagenaar E, Lagrois R, Schmidt B, Xia B, Ma D. Bailey JK, et al. Among authors: wagenaar e. J Biol Chem. 2015 Apr 3;290(14):8987-9001. doi: 10.1074/jbc.M114.623611. Epub 2015 Feb 9. J Biol Chem. 2015. PMID: 25666610 Free PMC article.

Cite

Share